Picture of GoodRx Holdings logo

GDRX — GoodRx Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapSuper Stock

GoodRx Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary

* GoodRx Holdings Inc  GDRX.OQ  reported quarterly adjusted
earnings of 8 cents​​ per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of 6 cents.  The mean expectation of
seventeen analysts for the quarter was for earnings of 9 cents
per share. Wall Street expected results to range from 7 cents
to 11 cents per share.
    * Revenue rose 8.5% to $195.25 million from a year ago;
analysts
expected $195.65 million. 
    * GoodRx Holdings Inc's reported EPS for the quarter was 1
cent​.
    * The company reported quarterly net income of $3.97
million.
    * GoodRx Holdings Inc shares had fallen by 12.0% this
quarter and
lost 8.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the online
services
peer group is also "buy"

Wall Street's median 12-month price target for GoodRx Holdings
Inc is $9.25 
This summary was machine generated from LSEG data November 7 at
02:42 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.09           0.08           Missed
 Jun. 30 2024                     0.08           
 Mar. 31 2024      0.08           0.08           Met
 Dec. 31 2023      0.07           0.08           Beat

Recent news on GoodRx Holdings

See all news